Skip to main content

Lloyd A. Rowland

Equibles does not estimate personal net worth.

Get an email with a short summary when CytomX Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CTMX alerts

About Lloyd A. Rowland

Lloyd A. Rowland is recorded as General Counsel at CytomX Therapeutics, Inc. (CTMX). The newest filing on record that lists Lloyd A. Rowland as General Counsel at CytomX Therapeutics, Inc. (CTMX) is dated April 27, 2023. The proxy statement of CytomX Therapeutics, Inc. reports total compensation of $1,205,166 for Lloyd A. Rowland in fiscal 2022, including a base salary of $425,193. Disclosed compensation is on record for 5 fiscal years. CytomX Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytomX Therapeutics, Inc. includes Sean McCarthy (CEO and Board Member), Chris Ogden (CFO and Chief Accounting Officer), Alan Ashworth (Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at CytomX Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 CytomX Therapeutics, Inc. (CTMX) $425,193 $1,205,166
2021 CytomX Therapeutics, Inc. (CTMX) $417,778 $1,421,758
2020 CytomX Therapeutics, Inc. (CTMX) $403,650 $953,393
2019 CytomX Therapeutics, Inc. (CTMX) $390,000 $1,097,843
2018 CytomX Therapeutics, Inc. (CTMX) $360,000 $26,586

Recent activity

No call appearances or filed executive changes recorded yet.